V outlook financial report | Porton Pharma Solutions Ltd(300363) : received US $681 million purchase orders from Pfizer’s companies

Porton Pharma Solutions Ltd(300363) (300363) announced on February 11 that recently, the company received from multinational pharmaceutical company Pfizer Inc. (hereinafter referred to as “Pfizer”) will provide contract customized R & D and production (cdmo) services for the new batch of purchase orders of Pfizer Ireland pharmaceuticals, and the order delivery time is 2022. As of the disclosure date of the announcement, the total amount of newly obtained orders was 681 million US dollars, exceeding 50% of the audited operating revenue of the company in the latest fiscal year.